| Literature DB >> 35525944 |
Mehdi Bakht1,2, Safar Ali Alizadeh1, Sara Rahimi1,2, Raana Kazemzadeh Anari1,2, Mohammad Rostamani1,2, Amir Javadi1,3, Amir Peymani1, Seyed Mahmoud Amin Marashi1, Farhad Nikkhahi4.
Abstract
BACKGROUND: Pseudomonas aeruginosa is a common pathogen in Hospitalized patients, and its various resistance mechanisms contribute to patient morbidity and mortality. The main aims of the present study were to assess the susceptibility of biofilm-producing and non-producing P. aeruginosa isolates to the five commonly used Hospital disinfectants, to evaluate the synergistic effect of selected disinfectants and Ethylene-diamine-tetra acetic acid (EDTA), and the effect of exposure to sub-inhibitory concentrations of Sodium hypochlorite on antimicrobial susceptibility test.Entities:
Keywords: Biofilm; Clinical isolates; Disinfectant-resistance; Hospital disinfectants; Nosocomial infection; Pseudomonas aeruginosa
Mesh:
Substances:
Year: 2022 PMID: 35525944 PMCID: PMC9078005 DOI: 10.1186/s12866-022-02524-y
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 4.465
Fig.1Graph of relative frequency distribution of P. aeruginosa isolates, according to the type of clinical isolation from patients and Hospitals
Biochemical test and identification of P. aeruginosa
| Gram Staining | Negative |
| Shape (Cocci/Diplococci/Rods) | Rods |
| Motility (Motile / Non-Motile) | Motile |
| Catalase | Positive |
| Oxidase | Positive |
| MR | Negative |
| VP | Negative |
| OF (Oxidative/Fermentative) | Oxidative |
| Indole | Negative |
| Citrate | Positive |
| Urease | Negative |
| H2S | Negative |
| Gas | Positive |
| Pigment | Positive |
| Cetrimide Test | Positive |
Percentage of antibiotic resistance and susceptibility by each antibiotic
| Amikacin | Sensitive | 45.6 | 0 | 0 |
| MDR | 24.9 | 7.5 | 5.8 | |
| XDR | 3.3 | 1.7 | 10.8 | |
| Gentamicin | Sensitive | 44 | 0 | 1.7 |
| MDR | 29 | 3.3 | 5.8 | |
| XDR | 2.5 | 1.7 | 11.6 | |
| Tobramycin | Sensitive | 45.7 | 0 | 0 |
| MDR | 30 | 1.7 | 6.6 | |
| XDR | 1.7 | 0.83 | 1.3 | |
| Meropenem | Sensitive | 39 | 0.83 | 5.8 |
| MDR | 25.7 | 5 | 7.5 | |
| XDR | 0 | 0.83 | 15 | |
| Imipenem | Sensitive | 12.5 | 17.4 | 15.8 |
| MDR | 7.5 | 15 | 15.8 | |
| XDR | 0.83 | 0.83 | 14.1 | |
| Ceftazidime | Sensitive | 39 | 5 | 1.7 |
| MDR | 14 | 16.6 | 7.5 | |
| XDR | 1.7 | 0 | 14.1 | |
| Cefepime | Sensitive | 44 | 0 | 1.7 |
| MDR | 24 | 10.8 | 3.3 | |
| XDR | 2.5 | 0.83 | 12.5 | |
| Cefoxitin | Sensitive | 0 | 0 | 45.8 |
| MDR | 0 | 0 | 38.3 | |
| XDR | 0 | 0 | 15.9 | |
| Piperacillin | Sensitive | 45.7 | 0 | 0 |
| MDR | 25.7 | 10.8 | 1.7 | |
| XDR | 5.8 | 0.83 | 9.1 | |
| Piperacillin/Tazobactam | Sensitive | 45.7 | 0 | 0 |
| MDR | 25.7 | 10.8 | 1.7 | |
| XDR | 6.6 | 0.83 | 8.3 | |
| Levofloxacin | Sensitive | 31.5 | 9.1 | 5 |
| MDR | 8.3 | 15.8 | 14.1 | |
| XDR | 1.7 | 0 | 14.1 | |
| Ampicillin/Sulbactam | Sensitive | 0 | 0 | 45.8 |
| MDR | 0 | 0 | 38.3 | |
| XDR | 0 | 0 | 15.9 | |
| Ciprofloxacin | Sensitive | 42.3 | 1.7 | 1.7 |
| MDR | 15.8 | 5.8 | 16.6 | |
| XDR | 0.83 | 0.83 | 14.1 | |
| Colistin | Sensitive | - | 45.7 | 0 |
| MDR | - | 34.9 | 3.3 | |
| XDR | - | 15.8 | 0 |
Antibiotic Susceptibility of clinical P. aeruginosa isolates before and after incubation with Sodium hypochlorite
| Sensitive | Intermediate | Resistance | Sensitive | Intermediate | Resistance | ||
|---|---|---|---|---|---|---|---|
| 78(65) | 8(6.7) | 34(28.3) | 65(54.2) | 15(12.5) | 40(33.3) | < 0.001 | |
| 25(20.8) | 40(33.3) | 55(45.8) | 16(13.3) | 40(33.3) | 64(53.3) | 0.004 | |
| 93(77.5) | 3(2.5) | 24(20) | 83(69.2) | 9(7.5) | 28(23.3) | 0.002 | |
| 89(74.2) | 11(9.2) | 20(16.7) | 82(68.3) | 12(10) | 26(21.7) | 0.016 | |
| 91(75.8) | 6(5) | 23(19.2) | 81(67.5) | 11(9.2) | 28(23.3) | 0.002 | |
| 85(70.8) | 14(11.7) | 21(17.5) | 76(63.3) | 18(15) | 26(21.7) | 0.004 | |
| 0(0) | 0(0) | 120(100) | 0(0) | 0(0) | 120(100) | - | |
| 66(55) | 26(21.7) | 28(23.3) | 60(50) | 28(23.3) | 32(26.7) | 0.031 | |
| 50(41.7) | 30(25) | 40(33.3) | 44(36.7) | 33(27.5) | 43(35.8) | < 0.001 | |
| 71(59.2) | 10(8.3) | 39(32.5) | 59(49.2) | 17(14.2) | 44(36.7) | < 0.001 | |
| 93(77.5) | 14(11.7) | 13(10.8) | 93(77.5) | 14(11.7) | 13(10.8) | 1 | |
(Beta-Lactamase Inhibitor) | 94(78.3) | 14(11.7) | 12(10) | 94(78.3) | 14(11.7) | 12(10) | 1 |
(Beta-Lactamase Inhibitor) | 0(0) | 0(0) | 120(100) | 0(0) | 0(0) | 120(100) | - |
| - | 116(96.7) | 4(3.3) | - | 116(96.7) | 4(3.3) | - | |
*Data were classified into sensitive and insensitive groups for statistical analysis. Intermediate group was considered as resistance
Fig. 2Diagram of the results of antibiotics susceptibility test A before exposure to sodium hypochlorite. B Comparative diagram of the results of antibiotics susceptibility test before (AST1) and after (AST2) exposure to sodium hypochlorite
The number (%) of isolates with MICs and MBCs
| Disinfectants | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | |
|---|---|---|---|---|---|---|---|---|
| Serial dilution → | ||||||||
| Ethanol 70% | Active ingredients → | |||||||
| MIC | 12(10) | 65(54.2) | 30(25) | 11(9.2) | 2(1.7) | _ | _ | |
| MIC + EDTA | 1(0.8) | 7(5.8) | 32(26.7) | 68(56.7) | 7(5.8) | 4(3.3) | 1(0.8) | |
| MBC | 59(49.2) | 34(28.3) | 25(20.8) | 1(0.8) | 1(0.8) | _ | _ | |
| MBC + EDTA | 3(2.5) | 25(20.8) | 51(42.5) | 34(28.3) | 6(5) | 1(0.8) | _ | |
Sodium hypochlorite 5% | Active ingredients → | |||||||
| MIC | _ | _ | _ | 15(12.5) | 50(41.7) | 30(25) | 25(20.8) | |
| MIC + EDTA | _ | _ | _ | 6(5) | 12(10) | 24(20) | 78(65) | |
| MBC | _ | _ | _ | 33(27.5) | 56(46.7) | 30(25) | 1(0.8) | |
| MBC + EDTA | _ | _ | _ | 14(11.7) | 24(20) | 59(49.2) | 23(19.2) | |
| Dettol 4.8% | Active ingredients → | |||||||
| MIC | _ | _ | _ | 42(35) | 39(32.5) | 39(32.5) | _ | |
| MIC + EDTA | _ | _ | _ | 5(4.2) | 26(21.7) | 44(36.7) | 45(37.5) | |
| MBC | _ | _ | _ | 65(54.2) | 42(35) | 13(10.8) | _ | |
| MBC + EDTA | _ | _ | _ | 32(26.7) | 43(35.8) | 37(30.8) | 8(6.7) | |
| Sayasept- HP 2% | Active ingredients → | |||||||
| MIC -HP | _ | _ | _ | 50(41.7) | 38(31.7) | 30(25) | 2(1.7) | |
| MIC + EDTA | _ | _ | _ | 13(10.8) | 29(24.2) | 36(30) | 42(35) | |
| MBC | _ | _ | 2(1.7) | 63(52.5) | 45(37.5) | 10(8.3) | _ | |
| MBC + EDTA | _ | _ | _ | 24(20) | 47(39.2) | 41(34.2) | 8(6.7) | |
| Chlorhexidine 2% | Active ingredients → | |||||||
| MIC | _ | _ | _ | 71(59.2) | 36(30) | 13(10.8) | _ | |
| MIC + EDTA | _ | _ | _ | 27(22.5) | 33(27.5) | 43(35.8) | 17(14.2) | |
| MBC | _ | _ | 44(36.7) | 64(53.3) | 12(10) | _ | _ | |
| MBC + EDTA | _ | _ | 16(13.3) | 56(46.7) | 48(40) | _ | _ |
The cells (-) means is not MBC/MIC for any of isolates
Fig. 3Comparative diagram of the results of antibiotics susceptibility test (MDR/XDR/Sensitive) in different concentration. A MBC Ethanol. B MBC Sodium hypochlorite. C MBC Dettol. D MBC Sayasept-HP. E MBC Chlorhexidine
Fig. 4Diagram of MBC disinfectants mixing with EDTA at different concentrations
Fig. 5Diagram of MBC disinfectants at different concentrations
Fig. 6Diagram of the relationship between biofilm formation strength and lethal strength (MBC) of disinfectants at different concentrations. A Ethanol alcohol. B Sodium hypochlorite. C Dettol. D Sayasept-HP. E Chlorhexidine
Fig. 7Diagram of gene distribution among sensitive MDR, and XDR isolates
Main properties of the five disinfectants used in the study
| Generic name Working | Manufacturer | Chemical composition |
|---|---|---|
| Domestic Bleach | Golrang, Iran | Sodium Hypochlorite (40 G/L) |
| Chlorhexidine Digluconate | Sigma-Aldrich | 20% (W/V) Chlorhexidine Digluconate |
| Ethanol | Razi, Iran | 70% (V/V) Ethanol |
| Dettol | British Company | Chloroxylenol Comprises 4.8% Of Dettol's |
| Sayasept-HP | Behban Chemistry, Iran | Fifth-Generate Qacs |
Active ingredient of disinfectants based on serial dilution.
| Disinfectant | 1/2 | 1/4 | 1/8 | 1/16 | 1/32 | 1/64 | 1/128 | 1/256 | 1/512 |
|---|---|---|---|---|---|---|---|---|---|
| Ethanol alcohol 70% | 35% | 17.5% | 8.75% | 4.37% | 2.18% | 1.09% | 0.54% | 0.27% | 0.136% |
| Sodium hypochlorite 5% | 2.5% | 1.25% | 0.62% | 0.31% | 0.156% | 0.078% | 0.039% | 0.019% | 0.0097% |
| Dettol 4.8% | 2.4% | 1.2% | 0.6% | 0.3% | 0.15% | 0.075% | 0.037% | 0.018% | 0.0093% |
| Sayasept- HP 2% | 1% | 0.5% | 0.25% | 0.125% | 0.062% | 0.031% | 0.015% | 0.007% | 0.0039% |
| Chlorhexidine 2% | 1% | 0.5% | 0.25% | 0.125% | 0.062% | 0.031% | 0.015% | 0.007% | 0.0039% |
Rideal-Walker Phenol Coefficient test
Values of biofilm formation by bacterial isolates
| OD values | Biofilm Formation |
|---|---|
| <ODc | None |
| ODc<ODt ≤ 2*ODc | Weak |
| 2*ODc<ODt ≤ 4*ODc | Moderate |
| 4*ODc<ODt | High |
The lists of primers were used in this study
| Target gene | Product size (bp) | Primer sequence (5ʹ →3ʹ) | Reference |
|---|---|---|---|
| 206 | F: 5ʹ-TGCGTTCCTGGATCTATCTG-3ʹ R: 5ʹ-GACGATGCCAATGCCTTC-3ʹ | In study | |
| 202 | F: 5ʹ-TTGTTATCGCAATAGTTG-3ʹ R: 5ʹ-AATGGCTGTAATTATGAC-3ʹ | In study | |
| 196 | F: 5ʹ-CCGTTGGTCTGAAATACAC-3ʹ R: 5ʹ-ATGGATTCGCCGAACAGG-3ʹ | In study | |
| 372 | F: 5ʹ-GCCAGTTGCGAGTAGATGTC-3ʹ R:5ʹ-CCGTGGAGTGAACCTGAATC-3ʹ | In study |
Temperature and time of different stages of PCR
| Final Extention | Extention | Anneling | Denaturation | Primery | Cycle number | Gene |
|---|---|---|---|---|---|---|
| denaturation | ||||||
| 10Min/72 | 50 s / 72 | 50 s / 53 | 1Min/94 | 5Min/94 | 30 | |
| 10Min/72 | 50 s / 72 | 45 s / 51 | 1Min/94 | 5Min/94 | 30 | |
| 10Min/72 | 50 s / 72 | 50 s / 53 | 1Min/94 | 5Min/94 | 30 | |
| 10Min/72 | 50 s / 72 | 50 s / 57 | 1Min/94 | 5Min/94 | 30 |